HOTH
Price:
$1.06
Market Cap:
$7.32M
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-003 to treat inflammatory bowel diseases, as well as acne and psoriasis; HT-004 for treatment of asthma and allergies using inhalational administration; HT-006 to treat lung dis...[Read more]
Industry
Biotechnology
IPO Date
2019-02-15
Stock Exchange
NASDAQ
Ticker
HOTH
According to Hoth Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.39. This represents a change of -52.49% compared to the average of -0.82 of the last 4 quarters.
The mean historical PE Ratio of Hoth Therapeutics, Inc. over the last ten years is -12.40. The current -0.39 PE Ratio has changed 214.54% with respect to the historical average. Over the past ten years (40 quarters), HOTH's PE Ratio was at its highest in in the March 2023 quarter at -0.59. The PE Ratio was at its lowest in in the December 2018 quarter at -41.87.
Average
-12.40
Median
-4.07
Minimum
-40.68
Maximum
-0.63
Discovering the peaks and valleys of Hoth Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.63
Minimum Annual Increase = -77.11%
Minimum Annual PE Ratio = -40.68
Year | PE Ratio | Change |
---|---|---|
2023 | -0.63 | -21.77% |
2022 | -0.80 | -22.31% |
2021 | -1.03 | -74.71% |
2020 | -4.07 | -44.79% |
2019 | -7.37 | -77.11% |
2018 | -32.21 | -20.81% |
The current PE Ratio of Hoth Therapeutics, Inc. (HOTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.82
5-year avg
-2.78
10-year avg
-12.40
Hoth Therapeutics, Inc.’s PE Ratio is less than Avenue Therapeutics, Inc. (-0.31), less than Revelation Biosciences, Inc. (-0.09), greater than NeuroBo Pharmaceuticals, Inc. (-0.73), greater than Virax Biolabs Group Limited (-1.34), greater than Zura Bio Limited (-9.00), less than Phio Pharmaceuticals Corp. (-0.15), greater than Sonnet BioTherapeutics Holdings, Inc. (-0.55), less than 180 Life Sciences Corp. (-0.14), greater than Cardio Diagnostics Holdings, Inc. (-0.75), less than Baudax Bio, Inc. (-0.21), less than TRACON Pharmaceuticals, Inc. (0.03), less than Aditxt, Inc. (-0.02), greater than Quoin Pharmaceuticals, Ltd. (-0.47), less than Allarity Therapeutics, Inc. (-0.19), less than Kiromic BioPharma, Inc. (-0.14), less than Biodexa Pharmaceuticals Plc (-0.05), less than Blue Water Vaccines, Inc. (-0.17), less than Hillstream BioPharma, Inc. (-0.00), less than Kiora Pharmaceuticals, Inc. (4.61),
Company | PE Ratio | Market cap |
---|---|---|
-0.31 | $4.05M | |
-0.09 | $1.43M | |
-0.73 | $29.70M | |
-1.34 | $15.24M | |
-9.00 | $230.86M | |
-0.15 | $2.25M | |
-0.55 | $4.53M | |
-0.14 | $1.89M | |
-0.75 | $6.94M | |
-0.21 | $8.13M | |
0.03 | $194.57K | |
-0.02 | $1.68M | |
-0.47 | $3.06M | |
-0.19 | $7.01M | |
-0.14 | $3.14M | |
-0.05 | $105.64K | |
-0.17 | $3.41M | |
-0.00 | $4.17M | |
4.61 | $10.52M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hoth Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hoth Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hoth Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Hoth Therapeutics, Inc. (HOTH)?
What is the highest PE Ratio for Hoth Therapeutics, Inc. (HOTH)?
What is the 3-year average PE Ratio for Hoth Therapeutics, Inc. (HOTH)?
What is the 5-year average PE Ratio for Hoth Therapeutics, Inc. (HOTH)?
How does the current PE Ratio for Hoth Therapeutics, Inc. (HOTH) compare to its historical average?